Menu
Washingtoner
  • Home
  • Business
  • Transportation
  • Aerospace
  • Technology
  • Construction
  • Manufacturing
  • Boeing
  • Kelly Ortberg
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • NIUFO Examines European MiCA Regulation's Impact on Digital Asset Trading Markets
  • AHRFD Releases Market Analysis: Cryptocurrency Market's Institutional Transformation Accelerating
  • Ubleu Crypto Group Analyzes European Digital Asset Market Opportunities Amid Regulatory Evolution
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • Spokane: Funding Available for Tourism and Cultural Investment Grants
  • Youth Take the Lead: Kopp Foundation for Diabetes Hosts "By Youth, For Youth, With T1D" Gala on October 8 at Blue Bell Country Club
  • Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025
  • CCHR, a Mental Health Watchdog Organization, Hosts Weekly Events Educating Citizens on Important Mental Health Issues
  • "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Counseling Center of New Smyrna Beach Expands Affordable Mental Health Services for Volusia County
  • Athena Forge (ATFG) Introduces Advanced Token for Technology-Driven Financial Ecosystem
  • Albuquerque's Z-CoiL Footwear Brings All-American Family Business Story to Shark Tank Season Premiere
  • NoviSign Sponsoring VARTECH 2025 - the B2B IT channel's #1 event
  • Unicorp and BH Group Select Chasing Creative—Palm Coast Agency—to Lead Growth Marketing for The Ritz-Carlton Residences, Hammock Dunes
  • Breaking: 50+ runners from 20+ states relay custom 9/11 flag 485 miles from Shanksville through DC to Ground Zero for memorial remembrance run
  • SecureMaine 2025 is this October 8th in Portland, Maine
  • John Thomas calls for unity and prayer after tragic loss
  • Where the Miami Dolphins Stand After Week 1
  • Which NFL Teams Can Rebound from Week 1? OddsTrader Breaks Down the Biggest Questions
  • South Tacoma Groundwater Protection District Code Updates Adopted by the Tacoma City Council
  • Apellix Deploys Breakthrough Spray-Painting Drones into Live Service Limited Beta Program Open for Advanced Contractors
  • DivX Unveils New Educational Blog Series to Simplify MKV to MP4 Video Conversion
  • SKYLAR DIGGINS ADVANCES TO PLAYOFFS AFTER WEARING 422 GRAMS OF PROTEIN--MADE WITH MILK
  • CCHR: For Prevention, Families Deserve Truth From NIH Study on Psychiatric Drugs
  • Sheets.Market Brings Professional Financial Model Templates to Entrepreneurs and Startups
  • Webinar Announcement: Investing in the European Defense Sector—How the New Era of Uncertainty Is Redefining Investment Strategies
  • AEVIGRA (AEIA) Analysis Reveals $350 Billion Counterfeit Market Driving Luxury Sector Toward Blockchain Authentication
  • Tacoma: City Council Unanimously Approves Funding for Immigrant Detainee Support
  • City Council Approves Lateral Incentive Program for Tacoma Police Department
_catLbl0 _catLbl1

Popular on Washingtoner

  • $5 - $20 Million in Sales for 2026; $25 - $40 Million for 2027 Projected with NASA Agreements; New MOU Signed to Improve Solar Tech in Space - 605
  • OddsTrader Asks: What Are the Chances Your Team Makes the NFL Playoffs? - 275
  • Ubleu Crypto Group Achieves FinCEN Registration and Colorado Incorporation, Accelerating U.S. Market Entry - 206
  • Iterators Named Preferred Accessibility Testing Vendor by MIT - 204
  • Benchmark International Successfully Facilitated the Trans of Bison Gardens and an Undisclosed Buyer - 199
  • Heritage at South Brunswick Announces Two New Building Releases In Townhome Collection - 177
  • Unlocking Amazon Savings: How Seller Promotional Codes Work — And How to Find Them Legitimately - 166
  • SQUARESIGNS Featured in Inc.5000 List Again - 137
  • Only 7 Days Left for Early Bird Registration to the OpenSSL Conference 2025 - 122
  • Assent Joins AWS ISV Accelerate Program - 112

Similar on Washingtoner

  • Your Body Isn't Broken—It's Out of Balance: The New Book Revealing the Blueprint to Restore Hormone Balance, Sleep, Gut & Metabolic Health
  • Youth Take the Lead: Kopp Foundation for Diabetes Hosts "By Youth, For Youth, With T1D" Gala on October 8 at Blue Bell Country Club
  • Counseling Center of New Smyrna Beach Expands Affordable Mental Health Services for Volusia County
  • Albuquerque's Z-CoiL Footwear Brings All-American Family Business Story to Shark Tank Season Premiere
  • NoviSign Sponsoring VARTECH 2025 - the B2B IT channel's #1 event
  • DivX Unveils New Educational Blog Series to Simplify MKV to MP4 Video Conversion
  • CCHR: For Prevention, Families Deserve Truth From NIH Study on Psychiatric Drugs
  • $40 Price Target for $NRXP in H. C. Wainright Analyst Report on Leader in $3 Billion Suicidal Depression Market with Superior NRX 100 Drug Therapy
  • Trinity Accounting Practice Celebrates 22 Years Serving Beverly Hills Businesses
  • AGEIMMUNE Launches Brilliant D3 + Magnesium & K2: A Doctor-Formulated Supplement for Bone, Immune & Heart Health Support
Copyright © 2025 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute